Pancreatic cancer
PRINCIPAL INVESTIGATORS
- Berta Maria Asuncion Laquente Saez
- Maria Cristina Manzanares Céspedes
POSTDOCTORAL RESEARCHERS
- Sandra Garcia Mulero
- Nicolás Peláez Llaneza
- Irene Peñuelas Haro
PREDOCTORAL RESEARCHERS
- Cristhian Ariel Acuña Pincay
- Klara Almagro Broncano
- Martin Jimenez Arriola
SCIENTIFIC SUPPORT
- Anton Vega Mendez
Cancer
Oncobell
Scientific production
9
PAPERS
Average IF: 19,49
6 PUBLICATIONS IN FIRST DECILE
7 PUBLICATIONS IN FIRST QUARTILE
7 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Amengual,J;Gonzalez Sanchez,E;Yanez Bartolome,M;Sererols Vinas,L;Ravichandra,A;Guiton,C;Fuste,NP et al, NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts, Signal Transduct Target Ther, 2025;10(1):257-257, doi:10.1038/s41392-025-02347-z
- Priego,N;de Pablos Aragoneses,A;Perea Garcia,M;Pieri,V;Hernandez Oliver,C;Alvaro Espinosa,L;Rojas,A et al, TIMP1 Mediates Astrocyte-Dependent Local Immunosuppression in Brain Metastasis Acting on Infiltrating CD8+ T Cells, Cancer Discov., 2025;15(1):179-201, doi:10.1158/2159-8290.CD-24-0134
- Castet,F;Fabregat Franco,C;Bridgewater,J;Kim,JW;Rimini,M;La Casta,A;Lamarca,A et al, Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer., J Hepatol, 2025;83(5):1102-1115, doi:10.1016/j.jhep.2025.05.020
- Marker,T;Steimbach,RR;Perez Borrajero,C;Luzarowski,M;Hartmann,E;Schleich,S;Pastor Flores,D et al, Site-specific activation of the proton pump inhibitor rabeprazole by tetrathiolate zinc centres., Nat Chem, 2025;17(4):507-517, doi:10.1038/s41557-025-01745-8
- Klein,L;Tu,M;Krebs,N;Urbach,L;Grimm,D;Latif,MU;Penz,F et al, Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer., Nat. Commun., 2025;16(1):335-335, doi:10.1038/s41467-024-55330-7
Research highlights
PROJECTS
1 Ongoing competitive project 1 Started Clinical trial 2 Ongoing Clinical trials
NETWORKS
TRANSPAN ALIPANC
Selected projects
- TRANSCAN2021-237. Targeting ROBOs and SLIT guidance cues in the immunosuppressive stromal context of pancreatic cancer (TRanSLIT). Asociación Española Contra el Cáncer (AECC). Budget: 302.600€. 2022-2025. PI: ELISA MARIA ESPINET HERNANDEZ.
- TTD-24-01 (PANSOTO). SOTORASIB COMBINADO CON QUIMIOTERÁPIA EN PRIMERA LÍNEA PARA ADENOCARCINOMA DE PÁNCREAS AVANZADO CON MUTACIÓN KRAS G12C. ESTUDIO PANSOTO. GRUPO TRAT.TUMORES DIGEST. Budget: 3.100€. 2025- . PI: BERTA MARIA ASUNCION LAQUENTE SAEZ.
- PDAC PATIENT EXPLANTS AS AN EX VIVO PLATFORM TO STUDY STROMAL RESPONSE TO CURRENT THERAPY AND EXPLORE NEW THERAPEUTIC OPTIONS.. Principal Investigator. 2023- . PI: Espinet Hernández, Elisa Maria.